Identifying Leukemia-associated Immunophenotypes in Acute Myeloid Leukemia Patients Using Multiparameter Flow Cytometry

Objectives: We sought to identify leukemia-associated immunophenotypes (LAIPs) in 50 acute myeloid leukemia (AML) patients at diagnosis using an eight-color multiparameter flow cytometry (MFC) panel and to detect if they showed any alteration in relapsed/refractory cases. Methods: We used the eight-...

Full description

Bibliographic Details
Main Authors: Hadeer Mohamed Rasheed, Hanaa Mahmoud Donia, Eman Attia Nadwan, Zeinab Ibrahim Mourad, Nahla Farahat
Format: Article
Language:English
Published: Oman Medical Specialty Board 2021-11-01
Series:Oman Medical Journal
Subjects:
Online Access:https://omjournal.org/articleDetails.aspx?coType=1&aId=3045
_version_ 1819094952069562368
author Hadeer Mohamed Rasheed
Hanaa Mahmoud Donia
Eman Attia Nadwan
Zeinab Ibrahim Mourad
Nahla Farahat
author_facet Hadeer Mohamed Rasheed
Hanaa Mahmoud Donia
Eman Attia Nadwan
Zeinab Ibrahim Mourad
Nahla Farahat
author_sort Hadeer Mohamed Rasheed
collection DOAJ
description Objectives: We sought to identify leukemia-associated immunophenotypes (LAIPs) in 50 acute myeloid leukemia (AML) patients at diagnosis using an eight-color multiparameter flow cytometry (MFC) panel and to detect if they showed any alteration in relapsed/refractory cases. Methods: We used the eight-color MFC panel with CD45/side scatter log gating strategy to analyze LAIPs in 50 AML patients presenting to Alexandria University Hospitals, Egypt at diagnosis and relapse and refractory cases. Twenty age and sex matched bone marrow samples from patients performing bone marrow aspirate for non-malignant hematological indications were included as controls. Results: LAIPs were observed in 43 (86.0%) cases. Only one aberrant immunophenotype was identified in four cases (9.3%), while two to 12 aberrant immunophenotypes were found in the other 39 (90.7%) cases. Strong LAIPs were obtained by combining CD2, CD4, CD56, with either CD34 or CD117, in contrast to CD19, which has to be combined with CD117. Refractory cases showed the presence of the same LAIPs at both initial diagnosis and persistent disease. One case showed the acquisition of new LAIPs after relapse. Conclusions: The good choice of LAIPs depends on their specificity rather than their frequency. The results of this study can help in increasing the sensitivity of LAIPs strategy in minimal residual disease using MFC in AML patients, which is considered an important post-diagnosis parameter associated with prognosis and clinical outcome.
first_indexed 2024-12-21T23:35:34Z
format Article
id doaj.art-ac11c1e7d67a4d2abcea79fa01a1c361
institution Directory Open Access Journal
issn 1999-768X
2070-5204
language English
last_indexed 2024-12-21T23:35:34Z
publishDate 2021-11-01
publisher Oman Medical Specialty Board
record_format Article
series Oman Medical Journal
spelling doaj.art-ac11c1e7d67a4d2abcea79fa01a1c3612022-12-21T18:46:22ZengOman Medical Specialty BoardOman Medical Journal1999-768X2070-52042021-11-01366e323e32310.5001/omj.2021.108Identifying Leukemia-associated Immunophenotypes in Acute Myeloid Leukemia Patients Using Multiparameter Flow CytometryHadeer Mohamed Rasheed0Hanaa Mahmoud Donia1 Eman Attia Nadwan2Zeinab Ibrahim Mourad3Nahla Farahat4Clinical Pathology Department, Faculty of Medicine, Alexandria University, Alexandria, EgyptClinical Pathology Department, Faculty of Medicine, Alexandria University, Alexandria, EgyptInternal Medicine Department, Faculty of Medicine, Alexandria University, Alexandria, EgyptClinical Pathology Department, Faculty of Medicine, Alexandria University, Alexandria, EgyptClinical Pathology Department, Faculty of Medicine, Alexandria University, Alexandria, EgyptObjectives: We sought to identify leukemia-associated immunophenotypes (LAIPs) in 50 acute myeloid leukemia (AML) patients at diagnosis using an eight-color multiparameter flow cytometry (MFC) panel and to detect if they showed any alteration in relapsed/refractory cases. Methods: We used the eight-color MFC panel with CD45/side scatter log gating strategy to analyze LAIPs in 50 AML patients presenting to Alexandria University Hospitals, Egypt at diagnosis and relapse and refractory cases. Twenty age and sex matched bone marrow samples from patients performing bone marrow aspirate for non-malignant hematological indications were included as controls. Results: LAIPs were observed in 43 (86.0%) cases. Only one aberrant immunophenotype was identified in four cases (9.3%), while two to 12 aberrant immunophenotypes were found in the other 39 (90.7%) cases. Strong LAIPs were obtained by combining CD2, CD4, CD56, with either CD34 or CD117, in contrast to CD19, which has to be combined with CD117. Refractory cases showed the presence of the same LAIPs at both initial diagnosis and persistent disease. One case showed the acquisition of new LAIPs after relapse. Conclusions: The good choice of LAIPs depends on their specificity rather than their frequency. The results of this study can help in increasing the sensitivity of LAIPs strategy in minimal residual disease using MFC in AML patients, which is considered an important post-diagnosis parameter associated with prognosis and clinical outcome.https://omjournal.org/articleDetails.aspx?coType=1&aId=3045flow cytometryleukemiamyeloidacuteimmunophenotypingneoplasmresidual
spellingShingle Hadeer Mohamed Rasheed
Hanaa Mahmoud Donia
Eman Attia Nadwan
Zeinab Ibrahim Mourad
Nahla Farahat
Identifying Leukemia-associated Immunophenotypes in Acute Myeloid Leukemia Patients Using Multiparameter Flow Cytometry
Oman Medical Journal
flow cytometry
leukemia
myeloid
acute
immunophenotyping
neoplasm
residual
title Identifying Leukemia-associated Immunophenotypes in Acute Myeloid Leukemia Patients Using Multiparameter Flow Cytometry
title_full Identifying Leukemia-associated Immunophenotypes in Acute Myeloid Leukemia Patients Using Multiparameter Flow Cytometry
title_fullStr Identifying Leukemia-associated Immunophenotypes in Acute Myeloid Leukemia Patients Using Multiparameter Flow Cytometry
title_full_unstemmed Identifying Leukemia-associated Immunophenotypes in Acute Myeloid Leukemia Patients Using Multiparameter Flow Cytometry
title_short Identifying Leukemia-associated Immunophenotypes in Acute Myeloid Leukemia Patients Using Multiparameter Flow Cytometry
title_sort identifying leukemia associated immunophenotypes in acute myeloid leukemia patients using multiparameter flow cytometry
topic flow cytometry
leukemia
myeloid
acute
immunophenotyping
neoplasm
residual
url https://omjournal.org/articleDetails.aspx?coType=1&aId=3045
work_keys_str_mv AT hadeermohamedrasheed identifyingleukemiaassociatedimmunophenotypesinacutemyeloidleukemiapatientsusingmultiparameterflowcytometry
AT hanaamahmouddonia identifyingleukemiaassociatedimmunophenotypesinacutemyeloidleukemiapatientsusingmultiparameterflowcytometry
AT emanattianadwan identifyingleukemiaassociatedimmunophenotypesinacutemyeloidleukemiapatientsusingmultiparameterflowcytometry
AT zeinabibrahimmourad identifyingleukemiaassociatedimmunophenotypesinacutemyeloidleukemiapatientsusingmultiparameterflowcytometry
AT nahlafarahat identifyingleukemiaassociatedimmunophenotypesinacutemyeloidleukemiapatientsusingmultiparameterflowcytometry